Can Droplets Improve Stem Cell Therapies?

By LifETIME CDT Student: Matthew Woods (University of Glasgow)   Stem cells are highly valuable in regenerative therapies because of their ability to change into several cell types. For example, mesenchymal stem cells can change into bone, cartilage or fat. When stem cells were first discovered it was thought that all the cells were identical, and all

A new avenue for spinal cord repair

By LifETIME CDT Student: Sorour Nemati (NUI Galway)   I am a chemical engineer whose ambition is to play a key role in human being life. Though it seems there is no specific role of chemical engineering in health care, its combination with other engineering streams such as biomedical engineering and biotechnology has introduced an

Rub-a-dub-dub cell sensors in the tub: monitoring cell therapies in bioreactors

By LifETIME CDT Student: Hannah Williamson (University of Birmingham)   Cell therapies, medicines made from human cells, have had huge success in fighting leaukemias and offer new hope to patients as treatments for a range of diseases. However, the manufacture of these therapies remains a major challenge and barrier to patient access. New technologies are

Alicia El Haj is awarded Midlands Women in Tech Award

By lifETIME CDT Administrator: Emma Lardner (University of Birmingham) Professor Alicia El Haj, Interdisciplinary Chair of Cell Engineering at the University of Birmingham and LifETIME CDT supervisor has won a Midlands Women in Tech Academic Award. Professor El Haj is a leading figure working within the field of healthcare technologies. She has been making signification contributions with

The TRAIL to a new era in cancer therapies: welcome to the age of immunotherapy

By LifETIME CDT Student: Aoibhin Sheedy (NUI Galway)   Immunotherapy is a promising approach for breakthrough therapies in the treatment of ovarian cancer, but there needs to be a robust investigation into suitable targets and delivery methods to solidify its true value for patients and clinicians. Ovarian cancer is the fourth leading cause of death due

1 2 3 7